Lataa...
Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis
Objective: To review the safety and efficacy of romosozumab (Evenity) in the treatment of osteoporosis in women. Data Sources: An English-language search of PubMed and Medline (1966 to August 2020) was conducted using the keywords romosozumab, sclerostin inhibitor, AMG785, and osteoporosis. Manufact...
Tallennettuna:
| Julkaisussa: | J Pharm Technol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809324/ https://ncbi.nlm.nih.gov/pubmed/34752536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122520967632 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|